T1	CHEM 1 11	Salbutamol
#1	AnnotatorNotes T1	C0001927; albuterol; Organic Chemical · Pharmacologic Substance
T2	CHEM 28 38	salbutamol
#2	AnnotatorNotes T2	C0001927; albuterol; Organic Chemical · Pharmacologic Substance
T3	DISO 60 74	crisis de asma
#3	AnnotatorNotes T3	C0038218; Status Asthmaticus; Disease or Syndrome | C0347950; Asthma attack; Disease or Syndrome
T4	PROC 76 122	Estudio aleatorizado, controlado y doble ciego
#4	AnnotatorNotes T4	C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T5	PROC 447 474	volumen espiratorio forzado
#5	AnnotatorNotes T5	C1306036; Forced expiratory volume procedure; Diagnostic Procedure
T6	CHEM 182 192	salbutamol
#6	AnnotatorNotes T6	C0001927; albuterol; Organic Chemical · Pharmacologic Substance
T7	CHEM 226 236	salbutamol
#7	AnnotatorNotes T7	C0001927; albuterol; Organic Chemical · Pharmacologic Substance
T8	DISO 263 271	síntomas
#8	AnnotatorNotes T8	C1457887; Symptoms; Sign or Symptom
T9	CHEM 748 758	salbutamol
#9	AnnotatorNotes T9	C0001927; albuterol; Organic Chemical · Pharmacologic Substance
T10	PROC 874 901	volumen espiratorio forzado
#10	AnnotatorNotes T10	C1306036; Forced expiratory volume procedure; Diagnostic Procedure
T11	CHEM 392 402	salbutamol
#11	AnnotatorNotes T11	C0001927; albuterol; Organic Chemical · Pharmacologic Substance
T12	CHEM 360 388	especialidades farmacéuticas
T13	DISO 416 420	asma
#12	AnnotatorNotes T13	C0004096; Asthma; Disease or Syndrome
T14	CHEM 517 527	salbutamol
#13	AnnotatorNotes T14	C0001927; albuterol; Organic Chemical · Pharmacologic Substance
T15	PROC 557 617	Estudio prospectivo, aleatorizado, controlado, a doble ciego
#14	AnnotatorNotes T15	C0013072; Double-Blind Method; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity + C0033522; Prospective Studies; Research Activity
T16	PROC 1052 1063	gravimetría
T17	CHEM 1317 1327	salbutamol
#15	AnnotatorNotes T17	C0001927; albuterol; Organic Chemical · Pharmacologic Substance
T18	PROC 504 512	tratados
#16	AnnotatorNotes T18	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T19	PROC 795 804	nebulizar
#17	AnnotatorNotes T19	C1659427; nebulization-mediated drug administration; Therapeutic or Preventive Procedure
T20	CHEM 1611 1621	salbutamol
#18	AnnotatorNotes T20	C0001927; albuterol; Organic Chemical · Pharmacologic Substance
T21	PROC 1086 1099	cromatografía
#19	AnnotatorNotes T21	C0008550; Chromatography; Laboratory Procedure
T22	CHEM 1750 1760	salbutamol
#20	AnnotatorNotes T22	C0001927; albuterol; Organic Chemical · Pharmacologic Substance
T23	PROC 1185 1212	volumen espiratorio forzado
#21	AnnotatorNotes T23	C1306036; Forced expiratory volume procedure; Diagnostic Procedure
T24	PROC 1739 1743	VEF1
#22	AnnotatorNotes T24	C1306036; Forced expiratory volume procedure; Diagnostic Procedure
T25	DISO 278 300	episodio agudo de asma
#23	AnnotatorNotes T25	C0038218; Status Asthmaticus; Disease or Syndrome | C0347950; Asthma attack; Disease or Syndrome
T26	CHEM 824 844	solución fisiológica
#24	AnnotatorNotes T26	C0445115; Normal saline; Inorganic Chemical · Pharmacologic Substance
T27	CHEM 1037 1047	salbutamol
#25	AnnotatorNotes T27	C0001927; albuterol; Organic Chemical · Pharmacologic Substance
T28	LIVB 50 55	niños
#26	AnnotatorNotes T28	C0008059; Child; Age Group
T30	LIVB 406 411	niños
#27	AnnotatorNotes T30	C0008059; Child; Age Group
T31	PHYS 324 350	respuesta broncodilatadora
#28	AnnotatorNotes T31	C3537072; Bronchodilation; Organ or Tissue Function | C3548479; response to bronchodilator; Organism Function
T33	LIVB 658 663	niños
#29	AnnotatorNotes T33	C0008059; Child; Age Group
T34	Age 682 698	9,18 ± 2,83 años
T35	Dose 716 744	una dosis de 20 gotas (5 mg)
T38	Form 781 789	solución
#30	AnnotatorNotes T38	C1382100; Solution Dosage Form; Biomedical or Dental Material
T39	Dose 816 820	2 ml
T40	Form 824 832	solución
#31	AnnotatorNotes T40	C1382100; Solution Dosage Form; Biomedical or Dental Material
T42	Duration 984 998	los 30 minutos
T43	Form 1028 1033	gotas
#32	AnnotatorNotes T43	C0015399; Eye Drops; Biomedical or Dental Material
T44	Form 1115 1120	gotas
#33	AnnotatorNotes T44	C0015399; Eye Drops; Biomedical or Dental Material
T45	PHYS 1149 1175	respuesta broncodilatadora
#34	AnnotatorNotes T45	C3537072; Bronchodilation; Organ or Tissue Function | C3548479; response to bronchodilator; Organism Function
T49	Form 1528 1533	gotas
#35	AnnotatorNotes T49	C0015399; Eye Drops; Biomedical or Dental Material
T54	Form 732 737	gotas
#36	AnnotatorNotes T54	C0015399; Eye Drops; Biomedical or Dental Material
T55	DEVI 1125 1131	envase
#37	AnnotatorNotes T55	C0013194; Drug Packaging; Medical Device
T29	LIVB 668 675	varones
#38	AnnotatorNotes T29	C0025266; Male population group; Population Group
T36	Time 902 920	prebroncodilatador
#39	AnnotatorNotes T36	C2599602; pre bronchodilator; Temporal Concept
T41	Time 923 941	posbroncodilatador
#40	AnnotatorNotes T41	C2599594; post bronchodilator; Temporal Concept
T53	Time 1213 1231	prebroncodilatador
#41	AnnotatorNotes T53	C2599602; pre bronchodilator; Temporal Concept
T56	Time 1234 1252	posbroncodilatador
#42	AnnotatorNotes T56	C2599594; post bronchodilator; Temporal Concept
T46	PHYS 1698 1724	respuesta broncodilatadora
#43	AnnotatorNotes T46	C3537072; Bronchodilation; Organ or Tissue Function | C3548479; response to bronchodilator; Organism Function
A1	Population_data T28 Age
A2	Population_data T30 Age
A3	Population_data T33 Age
T32	Neg_cue 1672 1674	No
T47	CONC 1680 1691	diferencias
A4	Assertion T47 Negated
#44	AnnotatorNotes T47	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T32 Arg2:T47	
T48	Quantifier_or_Qualifier 12 20	original
#45	AnnotatorNotes T48	C0205313; Original; Qualitative Concept
R2	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T48	
T50	Quantifier_or_Qualifier 193 201	original
#46	AnnotatorNotes T50	C0205313; Original; Qualitative Concept
R3	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T50	
T51	Quantifier_or_Qualifier 759 767	original
#47	AnnotatorNotes T51	C0205313; Original; Qualitative Concept
R4	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T51	
T52	Quantifier_or_Qualifier 528 536	original
#48	AnnotatorNotes T52	C0205313; Original; Qualitative Concept
R5	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T52	
T57	Quantifier_or_Qualifier 1622 1630	original
#49	AnnotatorNotes T57	C0205313; Original; Qualitative Concept
R6	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T57	
T58	Quantifier_or_Qualifier 1761 1769	original
#50	AnnotatorNotes T58	C0205313; Original; Qualitative Concept
R7	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T58	
T59	Quantifier_or_Qualifier 1328 1336	original
#51	AnnotatorNotes T59	C0205313; Original; Qualitative Concept
R8	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T59	
T60	Quantifier_or_Qualifier 39 46	similar
R9	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T60	
T61	Quantifier_or_Qualifier 539 546	similar
R10	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T61	
T62	Quantifier_or_Qualifier 770 777	similar
R11	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T62	
T63	Quantifier_or_Qualifier 1772 1779	similar
R12	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T63	
T64	Quantifier_or_Qualifier 237 244	similar
R13	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T64	
T65	Quantifier_or_Qualifier 1339 1346	similar
R14	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T65	
T66	Quantifier_or_Qualifier 1633 1640	similar
R15	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T66	
R16	Experiences Arg1:T28 Arg2:T1	
R17	Experiences Arg1:T28 Arg2:T2	
R18	Experiences Arg1:T28 Arg2:T3	
R19	Causes Arg1:T25 Arg2:T8	
R22	Causes Arg1:T11 Arg2:T31	
R23	Experiences Arg1:T30 Arg2:T11	
R24	Experiences Arg1:T30 Arg2:T13	
R25	Used_for Arg1:T14 Arg2:T18	
R26	Experiences Arg1:T30 Arg2:T18	
R28	Experiences Arg1:T30 Arg2:T5	
R31	Has_Age Arg1:T33 Arg2:T34	
R32	Has_Age Arg1:T29 Arg2:T34	
R34	Has_Dose_or_Strength Arg1:T9 Arg2:T35	
R35	Has_Drug_Form Arg1:T9 Arg2:T54	
R36	Has_Drug_Form Arg1:T9 Arg2:T38	
R37	Used_for Arg1:T9 Arg2:T19	
R38	Combined_with Arg1:T9 Arg2:T26	
R39	Has_Drug_Form Arg1:T26 Arg2:T40	
R40	Has_Dose_or_Strength Arg1:T26 Arg2:T39	
T67	Quantifier_or_Qualifier 849 858	única vez
R41	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T67	
R42	Overlap Arg1:T10 Arg2:T36	
R43	Overlap Arg1:T10 Arg2:T41	
T68	CONC 973 979	inicio
#52	AnnotatorNotes T68	C0439659; Beginning; Temporal Concept
R44	Overlap Arg1:T10 Arg2:T68	
R45	Overlap Arg1:T10 Arg2:T42	
R46	Has_Drug_Form Arg1:T27 Arg2:T43	
R47	Has_Drug_Form Arg1:T27 Arg2:T44	
R48	Overlap Arg1:T23 Arg2:T53	
R49	Overlap Arg1:T23 Arg2:T56	
R50	Causes Arg1:T17 Arg2:T45	
R53	Causes Arg1:T22 Arg2:T46	
R54	Overlap Arg1:T31 Arg2:T5	
R55	Experiences Arg1:T33 Arg2:T9	
R56	Experiences Arg1:T33 Arg2:T19	
T69	Spec_cue 167 174	sugiere
T70	Quantifier_or_Qualifier 208 218	más eficaz
A5	Assertion T70 Speculated
R57	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T70	
R58	Speculation Arg1:T69 Arg2:T70	
A6	Assertion T6 Speculated
R59	Speculation Arg1:T69 Arg2:T6	
A7	Assertion T50 Speculated
R60	Speculation Arg1:T69 Arg2:T50	
R20	Causes Arg1:T18 Arg2:T31	
T71	Spec_cue 476 478	si
T72	CONC 479 486	difiere
A8	Assertion T72 Speculated
#53	AnnotatorNotes T72	C1705241; Delta (difference); Quantitative Concept
R21	Speculation Arg1:T71 Arg2:T72	
R27	Overlap Arg1:T45 Arg2:T53	
R51	Overlap Arg1:T45 Arg2:T56	
#54	AnnotatorNotes T65	C2348205; Similarity; Qualitative Concept
#55	AnnotatorNotes T66	C2348205; Similarity; Qualitative Concept
#56	AnnotatorNotes T63	C2348205; Similarity; Qualitative Concept
#57	AnnotatorNotes T62	C2348205; Similarity; Qualitative Concept
#58	AnnotatorNotes T67	C1948045; Once (schedule frequency); Temporal Concept
#59	AnnotatorNotes T61	C2348205; Similarity; Qualitative Concept
#60	AnnotatorNotes T64	C2348205; Similarity; Qualitative Concept
#61	AnnotatorNotes T60	C2348205; Similarity; Qualitative Concept
#62	AnnotatorNotes T12	C4553142; Medicinal Product; Pharmacologic Substance
A9	Experiencer T28 Patient
A10	Experiencer T30 Patient
A11	Experiencer T33 Patient
A12	Experiencer T29 Patient
